Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1790 of 5804
-
Battle against superbugs: which antibiotic combo works best?
Disease control OngoingObjective of this study is to compare the efficacy and safety between combination of colistin and meropenem and combination of amikacin and meropenem for multi-drug-resistant gram-negative bacteria in Intensive Care Unit. In Beni- Suef University Hospital.
Phase: PHASE4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a special diet tame seizures in kids when drugs fail?
Disease control Not yet recruitingTo assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. …
Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug aims to restore skin color in vitiligo patients
Disease control Recruiting nowThe primary purpose of this study is to evaluate whether the drug EI-001 can help improve vitiligo symptoms. EI-001 is a novel antibody drug that affects the immune system to decrease uncontrolled inflammation. EI-001 has been investigated in human cell cultures, animal studies, …
Phase: PHASE2 • Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Gene therapy injection aims to halt vision loss in stargardt patients
Disease control Recruiting nowTo evaluate the preliminary safety of monocular and single subretinal injection of ZVS106e injection in the treatment of patients with hereditary retinal degeneration (ABCA4-IRDS) caused by ABCA4 biallelic mutations.
Phase: EARLY_PHASE1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could cord blood transplants slow ALS? new trial begins
Disease control ENROLLING_BY_INVITATIONAmyotrophic Lateral Sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder. Its global prevalence is approximately 0.73-1.89 per 100,000 individuals. In China, there are about 200,000 ALS patients, with approximately 25,000 new cases diagnosed annually. Mic…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Sound waves to soothe PTSD? new trial targets brain circuit in healthcare workers
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether low-intensity focused ultrasound (LIFU) of the ventral anterior cingulate cortex (vACC) can normalize dysfunctional brain activation patterns and behaviors in frontline healthcare workers with post-traumatic stress disorder. …
Phase: NA • Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Liver transplant drug showdown: which lowers pressure better?
Disease control Recruiting nowThe goal of this clinical trial is to compare the effects of somatostatin and terlipressin on lowering portal pressure in patients with portal hypertension undergoing liver transplantation, and to investigate whether there are differences in clinical outcomes between the two drug…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo therapy aims to restore hand function after stroke
Symptom relief Recruiting nowFollowing a stroke, the function of the distal upper limb, especially hand and finger movements, is often severely compromised, significantly restricting the ability to carry out daily activities. It is estimated that 55-75% of stroke survivors suffer from motor dysfunction, with…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Salt switch could shield Moms-to-Be from dangerous pregnancy complication
Prevention Not yet recruitingThe PREG-Salt study is to evaluate the effect, safety and cost-effectiveness of low-sodium salt in reducing blood pressure and preventing hypertensive disorders in pregnant women at high risk in China. The study will recruit about 3,200 participants from approximately 100 hospita…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
Can video games keep your brain and body young? new study tests exergaming vs. traditional exercise
Symptom relief Recruiting nowThe primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a common drug help cancer patients keep their appetite?
Symptom relief Recruiting nowThis phase II trial compares the effect of adding olanzapine to standard of care symptom management for nausea to standard of care alone in managing an abnormal loss of the appetite for food (anorexia) in patients treated with chemoradiation therapy (CRT) for head and neck cancer…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New pill aims to tame manic episodes in bipolar disorder
Symptom relief Recruiting nowThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an episode of mania with or without mixed features.
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New digital tool aims to curb antibiotic overuse in belgian Doctor's offices
Disease control Recruiting nowInappropriate antibiotic prescribing in primary care remains an important contributor to antimicrobial resistance. Despite the availability of evidence-based clinical guidelines, antibiotics are still frequently prescribed for self-limiting infections. Digital clinical decision s…
Phase: NA • Sponsor: KU Leuven • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Diagnosis Recruiting nowEvaluate the initial dose-effect and time-effect relationship of the injection product NC527-X
Phase: PHASE1 • Sponsor: Zhejiang Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
New eye drops aim to halt Vision-Threatening keratoconus
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if TN-001, a new eye-drop therapy, is safe and well-tolerated in adult patients with progressive keratoconus. It will also provide data on whether this therapy is effective in treating keratoconus. The main questions it aims to answer …
Phase: PHASE1, PHASE2 • Sponsor: TheiaNova Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New therapy aims to help mothers in recovery connect with their kids
Symptom relief Recruiting nowMothers with substance use disorders face unprecedented stress in their roles as parents working to care for their children while maintaining healthy recovery. Mothering from the Inside Out (MIO) is the first attachment-based parenting intervention designed specifically for mothe…
Phase: NA • Sponsor: Baystate Medical Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer. This study also aims to find the best amount of study m…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New rapid test could speed up UTI diagnosis and antibiotic choice
Diagnosis OngoingPerformance evaluation of QIAstat-Dx cUTI Plus AMR Panel using the QIAstat-Dx® Analyzer to demonstrate that the QIAstat-Dx cUTI Plus AMR Panel achieves its intended performance during normal conditions of use by the intended user in the intended environment
Sponsor: QIAGEN Gaithersburg, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New combo aims to fix chemo side effect in cancer survivors
Disease control Recruiting nowThis is a prospective, randomized, open-label, active-controlled study to evaluate the efficacy and safety of Romiplostim N01 plus all-trans retinoic acid (ATRA) compared with Romiplostim N01 alone in adults with persistent isolated chemotherapy-induced thrombocytopenia (PICIT) a…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New nerve block could cut opioid use for liver donors
Symptom relief CompletedPostoperative pain control plays a crucial role in enhancing recovery and improving early mobilization in living liver donors. The rectus-intercostal fascial plane (RIFP) block is a novel ultrasound-guided regional anesthesia technique that provides anterior abdominal wall analge…
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC